Explore the innovative subcutaneous delivery of isatuximab for multiple myeloma, enhancing patient experience and treatment ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

Multiple myeloma has long been a killer. Therapies are changing that. New drugs have made it possible to live much longer with the disease, and some scientists even see a possible cure down the road ...

In lab studies, researchers found that medical marijuana may help lower resistance to multiple myeloma drugs, but that hasn’t been tested in people. Bortezomib (Velcade), or “BTZ,” is a drug ...

If you have smoldering multiple myeloma, you will show the following on lab tests: M protein level of greater than 3 grams per deciliter in your blood. Or 500 milligrams or more of M protein on a ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...

Multiple Myeloma Research. Our multiple myeloma research begins in the laboratory, where we study the biology of myeloma cells and develop potential new drugs and immunotherapies. It also includes ...

In fact, 1 in 5 myeloma patients are diagnosed with the disease only because they’ve gone to the doctor for routine medical exams and had lab tests that revealed telltale changes in blood or ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory ...

Around 1,500 people with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and ...

For patients newly diagnosed with multiple myeloma, optimal outcomes start with a clear set of goals. "The primary goals of initial treatment are straightforward: relieve symptoms like anemia ...

Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...